| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.0007 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |